|
Dear CURE OM Community,
As the year winds down, we have a lot to be grateful for and a lot to share.
This fall was a busy one for our community. Alongside the 15th Annual CURE OM Global Science Meeting, the MRF joined patients and caregivers at the 2026 MRIE Uveal Melanoma Patient & Caregiver Educational Symposium at Thomas Jefferson University and partner organizations from across the melanoma community gathered in Baltimore for the MRF's Global Melanoma Coalition Meeting. Thank you to everyone who showed up, shared their story and helped move this work forward.
As the MRF celebrates the conclusion of our 30th anniversary and as we approach our end-of-year giving season, we encourage you to support CURE OM with a tax-deductible donation to support research, education and advocacy initiatives that will enable more progress for the OM community over the next three decades!
Thanks to a generous supporter, every dollar you contribute through December 31 will be matched dollar for dollar, up to $30,000, directly supporting the melanoma patient community.
| | |
We're grateful to be in this community with you and wish you and your loved ones a peaceful holiday season.
With gratitude,
Caroline Glavin
Education Program Manager, Rare Melanoma Subtypes
| | If you’re passionate about supporting the MRF’s mission to cure melanoma and are considering making a lasting impact, you can explore more ways to give this holiday season. Every gift helps fund mission critical programming and research benefitting the OM community. | |
15th Annual CURE OM Global Science Meeting Recap
| | |
On September 18, the MRF's CURE OM initiative hosted the 15th Annual CURE OM Global Science Meeting at Thomas Jefferson University in Philadelphia. Each year, this meeting brings together leading ocular melanoma researchers, clinicians, industry partners and patient advocates to share new findings and set priorities for the field.
This year’s sessions featured presentations on the latest research in genetics for early detection and discovery, novel targets in metastatic disease, patient stories, industry lightning talks and what’s next for immune-based therapies.
We are so thankful to Dr. Marlana Orloff, Dr. Andrew Aplin and the team at Jefferson for hosting and to every researcher and patient who took part. We look forward to sharing key takeaways with you as the meeting summary becomes available.
The following day, the MRF was proud to join the 2026 MRIE Uveal Melanoma Patient & Caregiver Educational Symposium at Jefferson, where we shared an update on MRF programs and support resources alongside fellow patient advocacy organizations.
| | Save the Date: Eyes on a Cure 2027 in Denver | | |
We are excited to share that the 16th annual Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium will take place April 16-18, 2027, at the Grand Hyatt Denver in Denver, CO, in collaboration with The Melanoma & Skin Cancer Institute.
Over the weekend, patients, caregivers and leading OM experts will come together for sessions on treatment updates, metastatic disease, low vision management and prosthetics, nutrition and wellness and dedicated breakout and support group time for patients, caregivers and those living with metastatic disease. Registration details are coming soon! Please visit the event page for more information.
| | A limited number of travel scholarships will be available for ocular melanoma patients and caregivers, each including up to $500 for transportation and two nights at the Grand Hyatt Denver. Whether you would like to help fund a scholarship or need one to attend, please start with our short survey. | | If you're interested in helping shape the Eyes on a Cure program, we'd love to hear from you. Reach out to us at cureom@melanoma.org. | | Join Us Nov. 16: Ask the Expert | A Year in Review for Uveal Melanoma | | |
Join leading uveal melanoma expert Marlana Orloff, MD, on Monday, November 16 at 7 PM ET for an interactive webinar exploring the most significant advances in uveal melanoma research and what they could mean for patients today.
During this session, Dr. Orloff will discuss:
- Key findings from recent research
- Emerging treatment approaches and clinical trial opportunities
- The potential for earlier intervention
- What's next in the evolving uveal melanoma landscape
You will also hear from Danet Peterson, "Eye Believe" podcast host and a uveal melanoma patient advocate who will share the patient perspective, highlighting her personal melanoma journey and the importance of staying informed and hopeful as new research continues to emerge.
Whether you're a patient, caregiver, family member or advocate, this webinar offers valuable insights into the latest developments shaping the future of uveal melanoma care.
Thank you to IDEAYA Biosciences for sponsoring this educational program and supporting patient education.
| | New Conversation Guides | Questions to Ask Your Doctor: Uveal Melanoma | | |
To help patients and caregivers feel more informed and empowered, we developed Questions to Ask Your Doctor resources for both primary and metastatic uveal melanoma. Questions to ask include: your diagnosis and treatment options, the specialists involved in your care, genetic and biomarker testing, scans, follow-up care and monitoring, managing side effects and quality of life, clinical trials and second opinions and more.
Being informed can help patients better understand their diagnosis, participate in treatment decisions and advocate for the care that best meets their needs.
Explore these free resources and more at melanoma.org.
| | |
Darovasertib Data Presented at ESMO 2026 Across the Uveal Melanoma Treatment Journey
At the European Society for Medical Oncology (ESMO) Congress in Madrid this October, IDEAYA Biosciences and Servier shared results from three clinical trials of darovasertib, an oral targeted therapy, in uveal melanoma.
For patients with metastatic uveal melanoma who are HLA-A*02:01-negative, the Phase 2/3 OptimUM-02 trial found that darovasertib plus crizotinib as a first treatment more than doubled the time patients lived without their cancer growing (a median of 6.9 months, compared with 3.1 months for standard treatment options).
Read the full release here.
| | |
New Data Show Promise for Combining Two Immunotherapies in Metastatic Uveal Melanoma
At the Society for Immunotherapy of Cancer (SITC) Annual Meeting this November, Immunocore shared early results from a Phase 1/2 trial that combined KIMMTRAK (tebentafusp) with brenetafusp.
In 17 patients who received the combination as their first treatment for metastatic disease, an estimated 70% were still living two years later. The combination shrank tumors in 29% of patients, and those responses lasted a median of about two years. It also kept the cancer from growing in 71% of patients.
Read the full release here.
| | |
Clinical Trial Spotlight: OptimUM-10
OptimUM-10 is a Phase 3 clinical trial for adults newly diagnosed with primary uveal melanoma that has not spread.
The study compares treatment with darovasertib before local therapy (plaque radiation, proton beam radiation or eye removal) to local therapy alone,and follows patients for up to three years to measure vision and tumor outcomes.
Learn more by using the MRF's Clinical Trial Finder.
| | |
Treatment Before Surgery or Radiation May Help Save Eyes and Vision
At the American Academy of Ophthalmology (AAO) 2026 meeting in October, Dr. Lauren Dalvin of Mayo Clinic presented early results from the OptimUM-09 trial, which gives darovasertib before local treatment for primary (non-metastatic) uveal melanoma. Among patients who would otherwise have needed their eye removed, 57% were able to keep their eye.
Read the full article here.
| | Patient Support and Resources | Support Groups: Space for Connection | |
We invite you to participate in our CURE OM online support group, which takes place monthly:
-
Fourth Thursday of each month from 7-8 PM EST / 4-5 PM PST :This evening group is facilitated by the MRF's Education Program Manager, Caroline Glavin, MSW. The group is open to all ocular melanoma patients and caregivers.
-
Holiday schedule: Because of the holidays, the group will meet one week early. The November group meets on Thursday, November 19, and the December group meets on Thursday, December 17.
This group is designed to foster emotional support, shared understanding and connection. Whether you're newly navigating an ocular melanoma diagnosis or have been living with it for years, this is a space to reflect, express feelings, explore coping strategies and find comfort in community.
For more information and to register, please reach out to cureom@melanoma.org.
| | Put the “fun” in fundraising with our CommUNITY Fundraising program! By raising life-saving funds, you, too, can help make a difference in melanoma research. Whether it's a holiday party, a birthday fundraiser or a #GivingTuesday campaign, host your own CommUNITY Fundraiser and help support the fight against melanoma. Contact us at volunteer@melanoma.org to learn more and get started! | |
The Miles for Melanoma Season Isn't Over Yet — Join Us for Our Final 5Ks!
| | |
The Miles for Melanoma season has been filled with community, connection and incredible impact! Across the country, members of OM community have come together to build teams, honor loved ones, celebrate survivors and raise vital funds for research, patient education and advocacy.
This fall, teams made an extraordinary difference nationwide! In Philadelphia, Team Steels Strong and Team Lombardi Party raised more than $3,308; in New York, Team All for Dave contributed over $6,400; in San Diego, Team Cary Strong Por Vida and Team Kimmie's Crew raised more than $5,100 and in Los Angeles, Team Fe de Abuela brought in an incredible $27,600+ helping to fund more OM research grants, extend patient education and enable OM community advocacy at the state and federal level.
And we're not finished yet! Join us for the Fort Myers Miles for Melanoma 5K on December 12 and our final event in Miami on Sunday, February 7, at Zoo Miami. Start an ocular melanoma team to honor someone special, celebrate survivorship, connect with others who understand and help advance research that brings hope to patients and families. Every team, every dollar and every mile makes a difference!
| | | | | |
MRF Resources for the OM Community
| | | | |